Butynamine

Butynamine
Systematic (IUPAC) name


N-tert-Butyl-N,2-dimethylbut-3-yn-2-amine
Clinical data
Identifiers
CAS Registry Number	3735-65-7
ATC code	None
PubChem	CID 189910
ChemSpider	164936
UNII	313QE5199Z^Y
ChEMBL	CHEMBL2104389
Chemical data
Formula	C₁₀H₁₉N
Molecular mass	153.26 g/mol
SMILES CC(C)(C)N(C)C(C)(C)C#C
InChI InChI=1S/C10H19N/c1-8-10(5,6)11(7)9(2,3)4/h1H,2-7H3 Key:PAVORIOUUILGMQ-UHFFFAOYSA-N

Butynamine is a tertiary (a highly hindered) aliphatic amine which has antihypertensive effects.^[1]

References

↑ BREST AN, ONESTI G, SWARTZ C, BERLINER H, MOYER JH (June 1962). "Butynamine hydrochloride as an antihypertensive agent". Current Therapeutic Research, Clinical and Experimental 4: 313–6. PMID 13872883.

Sympatholytic (and closely related) antihypertensives (C02)

Sympatholytics
(antagonize α-adrenergic
vasoconstriction)

Central

α₂ agonist	Clonidine Guanabenz Guanfacine Methyldopa^#

Adrenergic release inhibitors	Bethanidine Bretylium Debrisoquine Guanadrel Guanazodine Guanethidine Guanoclor Guanazodine Guanoxabenz Guanoxan

Imidazoline receptor agonist	Moxonidine Rilmenidine

Ganglion-blocking/nicotinic antagonist	Mecamylamine Pentolinium Trimethaphan

Peripheral

Indirect

MAOI	Pargyline^‡

Adrenergic uptake inhibitor	Bietaserpine Deserpidine Methoserpidine Rescinnamine Reserpine

Tyrosine hydroxylase inhibitor	Metirosine

Direct

α₁ blockers	Prazosin Indoramin Trimazosin Doxazosin Urapidil

Non-selective α blocker	Phentolamine

Other antagonists

Serotonin antagonist	Ketanserin Lidanserin

Endothelin antagonist (for PH)	dual (Bosentan, Macitentan) selective (Ambrisentan, Sitaxentan)

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Index of the circulatory system

Description	Anatomy Arteries head and neck arms chest abdomen legs Veins head and neck arms chest abdomen and pelvis legs Development Cells Physiology proteins

Disease	Congenital Neoplasms and cancer Lymphatic vessels Injury Vasculitis Other Symptoms and signs eponymous

Treatment	Procedures Drugs beta blockers channel blockers diuretics nonsympatholytic vasodilatory antihypertensives peripheral vasodilators renin–angiotensin system sympatholytic antihypertensives vasoprotectives